| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |